Cargando…

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. Most endometrial cancer cases are diagnosed at an early stage and have good prognosis. Unfortunately a subset of patients with early stage and low grade disease experience recurrence for reasons that remain un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogel, Rachel Isaksson, Pulver, Tanya, Heilmann, Wiebke, Mooneyham, Ashley, Mullany, Sally, Zhao, Xianda, Shahi, Maryam, Richter, James, Klein, Molly, Chen, Liqiang, Ding, Rui, Konecny, Gottfried, Kommoss, Stefan, Winterhoff, Boris, Ghebre, Rahel, Bazzaro, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058731/ https://www.ncbi.nlm.nih.gov/pubmed/27121063 http://dx.doi.org/10.18632/oncotarget.8821

Ejemplares similares

Establishment, Characterization and Downstream Application of Primary Ovarian Cancer Cells Derived from Solid Tumors
por: Sueblinvong, Thanasak, et al.
Publicado: (2012)

Systemic analysis of the expression and prognostic significance of USP31 in endometrial cancer
por: Huang, Yuzhen, et al.
Publicado: (2023)

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs
por: Habicht, Juri, et al.
Publicado: (2019)

An Efficacious Endometrial Sampler for Screening Endometrial Cancer
por: Han, Lu, et al.
Publicado: (2019)

PTEN Sequence Analysis in Endometrial Hyperplasia and Endometrial Carcinoma in Slovak Women
por: Gbelcová, H., et al.
Publicado: (2015)

Oncogenic Y68 frame shift mutation of PTEN represents a mechanism of docetaxel resistance in endometrial cancer cell lines
por: Zhang, Haiyang, et al.
Publicado: (2019)

Endometrial Cancer
por: Hunter, R. D.
Publicado: (1979)

Endometrial cancer
por: Sobel, Mara, et al.
Publicado: (2021)

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
por: Konecny, G E, et al.
Publicado: (2009)

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
por: Dore, Molly, et al.
Publicado: (2021)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
por: Dore, Molly, et al.
Publicado: (2021)

Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer
por: Chen, Qi, et al.
Publicado: (2015)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
por: van der Woude, Hannah, et al.
Publicado: (2022)

Genetics of Endometrial Cancers
por: Okuda, Tsuyoshi, et al.
Publicado: (2010)

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
por: Kommoss, Felix KF, et al.
Publicado: (2018)

Mechanisms of mutant β-catenin in endometrial cancer progression
por: Parrish, Molly L., et al.
Publicado: (2022)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
por: Sullivan, Stephanie A., et al.
Publicado: (2021)

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003)

Endometrial histopathology results and evaluation of endometrial cancer risk in geriatric women
por: Günakan, Emre, et al.
Publicado: (2018)

Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
por: Terzic, Milan Milosav, et al.
Publicado: (2020)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid
por: Yang, Jianing, et al.
Publicado: (2023)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
por: Song, Yong Jung, et al.
Publicado: (2023)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Hormonal Biology of Endometrial Cancer
por: Skinner, L. G.
Publicado: (1979)

Controversies in the Management of Endometrial Cancer
por: Hernandez, Enrique, et al.
Publicado: (2010)

Controversies in the Management of Endometrial Cancer
por: Masciullo, V., et al.
Publicado: (2010)

Imaging of endometrial and cervical cancer
por: Patel, Shilpa, et al.
Publicado: (2010)

Role of emmprin in endometrial cancer
por: Nakamura, Keiichiro, et al.
Publicado: (2012)

Postoperative radiotherapy for endometrial cancer
por: Choi, Eun Cheol, et al.
Publicado: (2012)

Adjuvant therapy for endometrial cancer
por: DeLeon, Maria C., et al.
Publicado: (2014)

Endometrial Cancer and The Role of Statins
por: Humayun, Ammar, et al.
Publicado: (2015)

Signalling pathways in endometrial cancer
por: Markowska, Anna, et al.
Publicado: (2014)

Aspirin and endometrial cancer risk
por: Brasky, Theodore M., et al.
Publicado: (2016)

Recent Advances in Endometrial Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2017)

Telomerase and Telomeres in Endometrial Cancer
por: Alnafakh, Rafah A. A., et al.
Publicado: (2019)

Immunohistochemical Markers in Endometrial Cancer
por: Mais, Valerio, et al.
Publicado: (2021)

New Insights into Endometrial Cancer
por: Paleari, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_421d5a1jdka4r2j1o34p3s6g48